The sterile blister packaging may be damaged, and sterility may be compromised.
Source facts
Action
URGENT MEDICAL DEVICE RECALL NOTIFICATION letters dated January 5, 2024 were sent to customers. Customers were instructed to cease use and quarantine all product subject to recall. Once Aesculap Customer Support receives the customer's acknowledgement form, they will contact the customer to arrange for credit and to have the current inventory returned.
Initiated
2024-01-09
Root cause
Packaging change control
Distribution
Worldwide - US Nationwide distribution in the states of KS, NJ and NY. The country of Canada.
Recall number
Z-1246-2024
Recall status
Open, Classified
CDRH record ID
205716
FDA classified
2024-03-01
Recall event number
93856
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.